Indivumed partners with cancer research specialist Helomics

Indivumed which has a large cancer biobank and Helomics Corporation (Helomics) has announced their collaboration to anal...

September 22, 2017 | Friday | News
GSK receives FDA nod for its triple drug inhaler

Bringing in much needed relief for patients suffering from Chronic Obstructive Pulmonary Disorder (COPD), the US FDA has...

September 21, 2017 | Thursday | News
Nacimbio signs agreement with MYLAN Laboratories

The National Immunobiological Company (Nacimbio) which is a part of Rostec State Corporation has signed an agreement wit...

September 19, 2017 | Tuesday | News
CSL Behring announces FDA approval of Privigen for the treatment of CIDP in adults

Global biotherapeutics leader CSL Behring announced that the U.S. Food and Drug Administration (FDA) has approved P...

September 15, 2017 | Friday | News
Bristol-Myers Squibb collaborates with ENHANZE technology

US based Bristol-Myers Squibb Company and Halozyme Therapeutics, Inc. has announced a global collaboration and lice...

September 15, 2017 | Friday | News
Invicro acquires Imanova to Expand Global Imaging Capabilities

Combined business delivers world-leading imaging capabilities to drive improved decision-making from early drug discover...

September 12, 2017 | Tuesday | News
Boehringer collaborates with Gubra to develop next generation obesity treatments

Germany based Boehringer Ingelheim has committed up to €250 million ($300 million) to work with Gubra on ...

September 11, 2017 | Monday | News
Targeted therapy for acute myeloid leukemia

Singapore - The steady march of progress in new treatments for patients with acute myeloid leukemia (AML), one of the de...

September 4, 2017 | Monday | News
Korean companies mull on using AI for drug discovery

In a bid to speed up drug discovery process and boost R&D efforts, Korea Pharmaceutical and Bio-pharma Manufacturers...

September 1, 2017 | Friday | News
FDA approved revolutionary immunotherapy for blood cancer patients

Singapore – The U.S. Food and Drug Administration (FDA) announced the approval of a new, cutting-edge gene therapy...

September 1, 2017 | Friday | News
New treatment for adults with relapsed or refractory acute lymphoblastic leukemia

Singapore- The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of ad...

August 18, 2017 | Friday | News
Swift announces the highest throughput single-cell methyl-seq library preparation method

Singapore - Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (N...

August 14, 2017 | Monday | News
Speeding up drug discovery process with Artificial Intelligence

Singapore: It’s estimated that, on average, to bring one new drug to the market can take 1,000 people, 12-15 years...

August 10, 2017 | Thursday | Opinion
Xarelto proven to be highly effective stroke prevention in patients with AF

Singapore - Cardiovascular diseases including heart diseases and stroke account for one-third of deaths (nearly 18 milli...

August 1, 2017 | Tuesday | News
Takeda, Tesaro ink strategic deal to co-develop and commercialize cancer drug

Japanese pharma giant Takeda pharmaceuticals has entered into a strategic licensing deal with US’s Tesaro  fo...

August 1, 2017 | Tuesday | News
CARB-X announces funding to speed treatments for the world’s deadliest super bugs

A year since launching, the international partnership CARB-X announced its second round of antibiotic research and ...

August 1, 2017 | Tuesday | News
Jim Spavins appointed to the advisory board of Catalent Applied Drug Delivery Institute

The Catalent Applied Drug Delivery Institute has announced Jim Spavins to their advisory board. He has over 36 years of...

July 31, 2017 | Monday | News
FROM TRADITIONAL TO ADVANCED: Drug delivery market on the growth curve in Asia

The field of drug delivery is highly interdisciplinary. This science of delivering a pharmaceutical compound in the huma...

July 26, 2017 | Wednesday | Analysis